DDW Editor Reece Armstrong speaks to Dr Laura Aguilar, CMO of Diakonos Oncology, about the challenges of treating glioblastoma (GBM) and the approaches the company is taking to help tackle this devastating disease. RA: Why has GBM remained such a hard cancer to treat? LA: First, GBM, also known as glioblastoma, the most aggressive form […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!